Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis. Stascheit F, Grittner U, Hoffmann S, Mergenthaler P, et al. J Neurol 2022 Sep 27. pii: 10.1007/s00415-022-11389.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stascheit F, Grittner U, Hoffmann S, Mergenthaler P, et al. Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis. J Neurol 2022 Sep 27. pii: 10.1007/s00415-022-11389.
PMID: 36166068